DANIEL KING: Open Payments
NPI 1760063812 · KAYSVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 105 payments from 23 companies in 2025. Trend: 2023 $950 · 2024 $1,052 · 2025 $2,001
Food & beverage: $2,001
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 15 | $241 |
| SANOFI-AVENTIS U.S. LLC | 8 | $236 |
| Novo Nordisk Inc | 15 | $195 |
| Dexcom, Inc. | 11 | $194 |
| Corcept Therapeutics | 9 | $194 |
| Medtronic, Inc. | 9 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Madrigal Pharmaceuticals | 2 | $90 |
| CeQur Corporation | 1 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
Products named: iLet Bionic Pancreas, TZIELD, Dexcom G6 Transmitter, Korlym, MINIMED 780G, Wegovy, JARDIANCE, REZDIFFRA.
Industry payments across UT — which companies pay providers there.
